International Clinical Trial: An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220603) titled 'An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)' on Oct. 22.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: PepGen Inc

Condition: Myotonic Dystrophy 1

Intervention: Drug: PGN-EDODM1

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 2025

Target Sample Size: 48

To know more, visit https://clinicaltrials.gov/study/NCT07220603

Disclaimer: Curated by HT Syndication....